Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma.
about
Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses.Pegylated interferon for the adjuvant treatment of melanoma: FDA approved, but what is its role?Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma.Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective.Sylatron: a pegylated interferon for use in melanoma.Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma.An update on pegylated IFN-α2b for the adjuvant treatment of melanoma.
P2860
Q34117131-57E8BC24-5268-4989-B5CA-B49A2BC0EFE8Q36349569-59DE0834-7253-444B-94D6-A676504A6CBAQ36927476-685D482C-28FA-4AE8-848C-42A7C747485EQ37412789-15231D83-D447-4D84-87F9-B8687CCC0862Q38007892-383D62EC-8FC8-4CC7-B3B7-1A6D50E459F3Q38012440-87DC2766-E503-4247-B752-B4B6798F6A51Q38018370-16F8606C-75F9-4854-A9CE-7C612539A34EQ38068207-7C44825D-A6D3-4CC4-A9A3-0C464F8F4DE3
P2860
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@ast
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@en
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@nl
type
label
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@ast
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@en
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@nl
prefLabel
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@ast
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@en
Pharmacokinetic/pharmacodynami ...... h resected high-risk melanoma.
@nl
P2093
P2860
P1476
Pharmacokinetic/pharmacodynami ...... th resected high-risk melanoma
@en
P2093
L C Floren
N E Papadopoulos
R C Deconti
V K Sondak
P2860
P2888
P304
P356
10.1007/S00280-010-1326-9
P50
P577
2010-05-28T00:00:00Z
P5875
P6179
1025053342